XML 39 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Ordinary shares [Member]
Additional paid in capital [Member]
Accumulated deficit [Member]
Total
Beginning balance at Dec. 31, 2019 [1] $ 30,117 $ (17,744) $ 12,373
Beginning balance (in shares) at Dec. 31, 2019 [1] 9,274,838      
Share-based compensation   130   130
Issuance of shares   3,000   3,000
Exercise of warrants   1,250   1,250
Net loss for the year     (5,951) (5,951)
Ending balance at Dec. 31, 2020 [1] 34,497 (23,695) $ 10,802
Ending balance (in shares) at Dec. 31, 2020 9,274,838 [1]     9,274,838
Share-based compensation   2,019   $ 2,019
Effect of reverse capitalization transaction   2,476   2,476
Effect of reverse capitalization transaction (In shares) 152,299,702      
Issuance of shares and warrants, net of issuance costs   58,637   58,637
Issuance of shares and warrants, net of issuance costs (In shares) 66,381,520      
Exercise of Options   10   10
Exercise of Options, shares 134,240      
Net loss for the year     (12,478) (12,478)
Ending balance at Dec. 31, 2021 $ 97,639 $ (36,173) $ 61,466
Ending balance (in shares) at Dec. 31, 2021 228,090,300     228,090,300
[1] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)